Search
for
Sort by
Research 91–120 of 1000+
- Female Serum HER2 Expression: Its Association With Metabolic Syndrome and Treatment Drug Response
- Response to the article, “Evaluation of standardized scalp photography on patient perception of hair loss severity, anxiety, and treatment,” by Pathoulas et al
- Case Report: Pulsed electric field treatment of metastatic liver disease demonstrating a possible abscopal response
- Supplemental Figure 1 for "Time to Maximal Response with Low-Dose Oral Minoxidil in Clinical Treatment of Androgenetic Alopecia"
- Supplemental Figure 1 for "Time to Maximal Response with Low-Dose Oral Minoxidil in Clinical Treatment of Androgenetic Alopecia"
- Case Report: Pulsed electric field treatment of metastatic liver disease demonstrating a possible abscopal response
- Case Report: Pulsed electric field treatment of metastatic liver disease demonstrating a possible abscopal response
- Response to Buontempo et al., “Response to Nathalie Y. Ly and colleagues ‘Medical and procedural treatment of androgenetic alopecia - Where are we?’”
- Affect of a six months treatment regiment of metformin (MET) on 17-hydroxyprogesterone (17P) responses to GnRH agonist (GnRH Ag) in polycystic ovary syndrome (PCOS)
- Pathological Insights into the Limitations of Clinical and Dermoscopic Evaluations in Monitoring Sonidegib Treatment Response for Locally Advanced Basal Cell Carcinoma: A Real-World Study
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors
- Alopecia areata in children:, response to treatment with diphencyprone
- Transcriptome Profiling of Human Follicle Dermal Papilla Cells in response to Porphyra-334 Treatment by RNA-Seq
- Expression profile analysis of dermal papilla cells mRNA in response to WNT10B treatment
- Beyond PRP : Recognizing the Evolving Generations of Platelet Concentrates in Androgenetic Alopecia Treatment—A Letter in Response to Zhong Et al
- Timing of Initial Hair Regrowth and Clinical Trial-Defined Response Following Ritlecitinib Treatment in Patients With Alopecia Areata
- Understanding Eyebrow and Eyelash Involvement in Patients with Alopecia Areata and Responsiveness to Treatment with Baricitinib.
- Sex-Chromosome-Related Dimorphism in Steroidogenic Enzymes and Androgen Receptor in Response to Testosterone Treatment: An In Vitro Study on Human Primary Skeletal Muscle Cells
- 860 Understanding cellular & molecular responses in the treatment of pediatric lymphatic anomalies
- 1640: Polymorphisms in the 5α-Reductase Type 2 Gene and Response to Finasteride Treatment in BPH
- Figure 10, Photographic evaluation of treatment response to finasteride a – pre treatment b – post treatment
- Multifunctional Hydrogel with Dual Functions of ROS Scavenging and Responsive Antibiotic Release for Synergistic Oral Mucositis Treatment
- Clinicopathology, Trichoscopy, and Treatment Responsiveness of Folliculitis Decalvans: A Case Series of Three Pediatric Cases
- State of the art in the management of migraine—A response to the American College of Physicians migraine preventive treatment guideline
- A New Immune-Biochemical Study To Identify Indicators Of The Response Of Infertile Polycystic Ovary Syndrome Patients To Metformin Treatment
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment
- Unique Tumor Heterogeneity Within a Single Locally Advanced Basal Cell Carcinoma Resulting in Partial Response Despite Continuous Vismodegib Treatment
- Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.